🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Nikkei flat as profit-taking offsets vaccine optimism

Published 11/17/2020, 11:34 AM
Updated 11/17/2020, 11:40 AM
© Reuters.
JP225
-
TOPX
-
8035
-
9202
-
6954
-
9201
-
IINSU.T
-
IMING.T
-
IRLTY.T
-
MTHR
-
MRNA
-

TOKYO, Nov 17 (Reuters) - Japanese shares were flat on
Tuesday as investors booked profits following the recent surge
in the benchmark index, even as news of another promising
coronavirus vaccine re-ignited hopes of a swift global recovery.
The Nikkei share average .N225 , which has gained 12.6% so
far this month, was nearly flat at 25,913.41 by the midday
break. It briefly touched its highest since May 1991 in early
trade, tracking overnight gains on Wall Street.
The benchmark index on Monday closed at a 29-year high after
the economy posted its first expansion in four quarters.

"The market has been overheated by a high-paced rise, and it
would be no wonder if stocks go into correction at any time in
the short term," said Maki Sawada, equity market strategist at
Nomura Securities.
The S&P 500 and Dow Jones industrial average notched record
closing highs on Monday after Moderna Inc MRNA.O said its
experimental COVID-19 vaccine was 94.5% effective in preventing
infection based on interim late-stage data. The broader Topix .TOPX eased 0.26% to 1,727.39. Nearly
half of the 33 sector sub-indexes on the Tokyo exchange traded
higher.
The airline sector led gains, rising 3.61%, with ANA
Holdings 9202.T and Japan Airlines 9201.T adding 4% and 3%,
respectively.
Other cyclical sectors followed, with insurers .IINSU.T
climbing 2.56%, miners .IMING.T adding 2.46% and real estate
.IRLTY.T up 1.49%.
Semiconductor Tokyo Electron 8035.T rose 1.2% to a record
high, taking positive cues from its U.S. peers.
Nikkei's heavyweight Fanuc Corp 6954.T rose nearly 1.8%,
helped by upbeat industrial output data from China and the
formation of a regional trade bloc comprising 15 Asia-Pacific
economies. The Mothers Index .MTHR of start-up firm shares, however,
dropped 3.73%.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.